中文版 | English

在结果中检索

CASIA OpenIR

浏览/检索结果: 共4条，第1-4条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Identification of HDAC9 as a viable therapeutic target for the treatment of gastric cancer 期刊论文
EXPERIMENTAL AND MOLECULAR MEDICINE, 2019, 卷号: 51, 页码: 15
作者:  Xiong, Kai;  Zhang, Hejun;  Du, Yang;  Tian, Jie;  Ding, Shigang
收藏  |  浏览/下载：201/0  |  提交时间：2019/12/16
Antitumorigenic and antiangiogenic efficacy of apatinib in liver cancer evaluated by multimodality molecular imaging 期刊论文
EXPERIMENTAL AND MOLECULAR MEDICINE, 2019, 卷号: 51, 页码: 11
作者:  Liang, Qian;  Kong, Lingxin;  Du, Yang;  Zhu, Xu;  Tian, Jie
Adobe PDF(2847Kb)  |  收藏  |  浏览/下载：418/101  |  提交时间：2019/12/16
Preclinical comparison of regorafenib and sorafenib efficacy for hepatocellular carcinoma using multimodality molecular imaging 期刊论文
CANCER LETTERS, 2019, 卷号: 453, 页码: 74-83
作者:  Liu, Shengnan;  Du, Yang;  Ma, He;  Liang, Qian;  Zhu, Xu;  Tian, Jie
收藏  |  浏览/下载：243/0  |  提交时间：2019/07/12
Hepatocellular carcinoma  Regorafenib  Sorafenib  Molecular imaging  Therapeutic effects  
PD-1 blockade in combination with zoledronic acid to enhance the antitumor efficacy in the breast cancer mouse model 期刊论文
BMC CANCER, 2018, 卷号: 18, 页码: 7
作者:  Li, Yuan;  Du, Yang;  Sun, Ting;  Xue, Huadan;  Jin, Zhengyu;  Tian, Jie
Adobe PDF(4369Kb)  |  收藏  |  浏览/下载：422/190  |  提交时间：2019/02/18
PD-1  Zoledronic acid  Breast cancer  Therapy  Checkpoint inhibitior